NCT04128696
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04128696
Title Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (INDUCE-3)
Acronym INDUCE-3
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ROU | POL | NOR | NLD | ITA | ISR | IRL | GRC | GBR | FRA | ESP | DNK | DEU | CHE | CAN | BRA | AUS | ARG

Facility Status City State Zip Country Details
GSK Investigational Site Duarte California 91010 United States Details
GSK Investigational Site Washington D.C. District of Columbia 20010 United States Details
GSK Investigational Site St. Petersburg Florida 33705 United States Details
GSK Investigational Site Indianapolis Indiana 46202 United States Details
GSK Investigational Site Boston Massachusetts 02215 United States Details
GSK Investigational Site Charlotte North Carolina 28204 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19111 United States Details
GSK Investigational Site Pittsburgh Pennsylvania 15232 United States Details
GSK Investigational Site Charleston South Carolina 29425 United States Details
GSK Investigational Site Greenville South Carolina 29607 United States Details
GSK Investigational Site Chattanooga Tennessee 37404 United States Details
GSK Investigational Site Nashville Tennessee 37203 United States Details
GSK Investigational Site Seattle Washington 98108 United States Details
GSK Investigational Site Ciudad Autónoma de Buenos Aires Buenos Aires C1125ABD Argentina Details
GSK Investigational Site La Plata Buenos Aires 1900 Argentina Details
GSK Investigational Site Buenos Aires C1426ABP Argentina Details
GSK Investigational Site San Juan J5402DIL Argentina Details
GSK Investigational Site Blacktown New South Wales 2148 Australia Details
GSK Investigational Site St Leonards New South Wales 2065 Australia Details
GSK Investigational Site Herston Queensland 4029 Australia Details
GSK Investigational Site Heidelberg Victoria 3084 Australia Details
GSK Investigational Site Melbourne Victoria 3000 Australia Details
GSK Investigational Site Nedlands Western Australia 6009 Australia Details
GSK Investigational Site Darlinghurst 2010 Australia Details
GSK Investigational Site Vitória Espírito Santo 29043-260 Brazil Details
GSK Investigational Site Florianópolis Santa Catarina 88034-000 Brazil Details
GSK Investigational Site Barretos São Paulo 14784-400 Brazil Details
GSK Investigational Site São José do Rio Preto São Paulo 15090-000 Brazil Details
GSK Investigational Site Belo Horizonte, Minas Gerais 30150-221 Brazil Details
GSK Investigational Site São Paulo 01246-000 Brazil Details
GSK Investigational Site São Paulo 04014-002 Brazil Details
GSK Investigational Site Calgary Alberta T2N 4N2 Canada Details
GSK Investigational Site Edmonton Alberta T6G 1Z2 Canada Details
GSK Investigational Site Vancouver British Columbia V5Z 4E6 Canada Details
GSK Investigational Site Hamilton Ontario L8V 5C2 Canada Details
GSK Investigational Site Toronto Ontario M5G 1Z5 Canada Details
GSK Investigational Site Montreal Quebec H2X 3E4 Canada Details
GSK Investigational Site Montreal Quebec H3T 1E2 Canada Details
GSK Investigational Site Québec Quebec G1J 1Z4 Canada Details
GSK Investigational Site Rimouski Quebec G5L 5T1 Canada Details
GSK Investigational Site Guangzhou Guangdong 510060 China Details
GSK Investigational Site Guangzhou Guangdong 510503 China Details
GSK Investigational Site Nanning Guangxi 530021 China Details
GSK Investigational Site Guiyang Guizhou 550000 China Details
GSK Investigational Site Wuhan Hubei 430022 China Details
GSK Investigational Site Nanchang Jiangxi 330029 China Details
GSK Investigational Site Chengdu Sichuan 610000 China Details
GSK Investigational Site Chengdu Sichuan 610041 China Details
GSK Investigational Site Bengbu 233000 China Details
GSK Investigational Site Harbin 150000 China Details
GSK Investigational Site Hefei 230001 China Details
GSK Investigational Site Shnghai 200126 China Details
GSK Investigational Site Copenhagen DK-2100 Denmark Details
GSK Investigational Site Bordeaux 33000 France Details
GSK Investigational Site Epagny Metz-Tessy 74370 France Details
GSK Investigational Site Le Mans 72000 France Details
GSK Investigational Site Lille 59000 France Details
GSK Investigational Site Lyon 69373 France Details
GSK Investigational Site Paris 75005 France Details
GSK Investigational Site Saint-Herblain 44805 France Details
GSK Investigational Site Strasbourg 67200 France Details
GSK Investigational Site Toulouse 31059 France Details
GSK Investigational Site Valenciennes 59322 France Details
GSK Investigational Site Ulm Baden-Wurttemberg 89075 Germany Details
GSK Investigational Site Aachen North Rhine-Westphalia 52074 Germany Details
GSK Investigational Site Leipzig Saxony 04103 Germany Details
GSK Investigational Site Berlin 12200 Germany Details
GSK Investigational Site Hamburg 20246 Germany Details
GSK Investigational Site Hamburg 22087 Germany Details
GSK Investigational Site Heraklion,Crete 71110 Greece Details
GSK Investigational Site Thessaloniki 54622 Greece Details
GSK Investigational Site Thessaloniki 54645 Greece Details
GSK Investigational Site Dublin 8 Ireland Details
GSK Investigational Site Dublin D09 V2N0 Ireland Details
GSK Investigational Site Jerusalem 91120 Israel Details
GSK Investigational Site Petah Tikva 49100 Israel Details
GSK Investigational Site Ramat Gan 52621 Israel Details
GSK Investigational Site Meldola (FC) Emilia-Romagna 47014 Italy Details
GSK Investigational Site Brescia Lombardy 25123 Italy Details
GSK Investigational Site Milan Lombardy 20133 Italy Details
GSK Investigational Site Milan Lombardy 20141 Italy Details
GSK Investigational Site Candiolo Piedmont 10060 Italy Details
GSK Investigational Site Legnago (VR) Veneto 37045 Italy Details
GSK Investigational Site Chiba 260-8717 Japan Details
GSK Investigational Site Chiba 277-8577 Japan Details
GSK Investigational Site Ehime 791-0280 Japan Details
GSK Investigational Site Fukuoka 812-8582 Japan Details
GSK Investigational Site Hokkaido 060-8648 Japan Details
GSK Investigational Site Hyōgo 673-8558 Japan Details
GSK Investigational Site Ibaraki 305-8576 Japan Details
GSK Investigational Site Kagawa 761-0793 Japan Details
GSK Investigational Site Kanagawa 259-1143 Japan Details
GSK Investigational Site Miyagi 981-1293 Japan Details
GSK Investigational Site Niigata 951-8520 Japan Details
GSK Investigational Site Numakunai 028-3695 Japan Details
GSK Investigational Site Osaka 534-0021 Japan Details
GSK Investigational Site Saitama 362-0806 Japan Details
GSK Investigational Site Shizuoka 411-8777 Japan Details
GSK Investigational Site Tokyo 113-8431 Japan Details
GSK Investigational Site Tokyo 113-8519 Japan Details
GSK Investigational Site Saltillo Coahuila 25279 Mexico Details
GSK Investigational Site Guadalajara Jalisco 44680 Mexico Details
GSK Investigational Site Maastricht 6229 HX Netherlands Details
GSK Investigational Site Rotterdam 3015 GD Netherlands Details
GSK Investigational Site Bergen 5021 Norway Details
GSK Investigational Site Oslo 0379 Norway Details
GSK Investigational Site Bydgoszcz 85-796 Poland Details
GSK Investigational Site Gdynia 81-519 Poland Details
GSK Investigational Site Gliwice 44-101 Poland Details
GSK Investigational Site Krakow 31-826 Poland Details
GSK Investigational Site Olsztyn 10-228 Poland Details
GSK Investigational Site Tomaszów Mazowiecki 97-200 Poland Details
GSK Investigational Site Warsaw 02-781 Poland Details
GSK Investigational Site Coimbra 3000-075 Portugal Details
GSK Investigational Site Lisbon 1649-035 Portugal Details
GSK Investigational Site Matosinhos Municipality 4454-509 Portugal Details
GSK Investigational Site Porto 4200-072 Portugal Details
GSK Investigational Site Porto 4200-319 Portugal Details
GSK Investigational Site Brasov 500283 Romania Details
GSK Investigational Site Bucharest 021389 Romania Details
GSK Investigational Site Cluj-Napoca 400015 Romania Details
GSK Investigational Site Constanța 900591 Romania Details
GSK Investigational Site Craiova 200347 Romania Details
GSK Investigational Site Floreşti 407280 Romania Details
GSK Investigational Site Iași 700106 Romania Details
GSK Investigational Site Oradea 410469 Romania Details
GSK Investigational Site Otopeni 075100 Romania Details
GSK Investigational Site Satu Mare 440055 Romania Details
GSK Investigational Site Suceava 720284 Romania Details
GSK Investigational Site Moscow 111123 Russia Details
GSK Investigational Site Poselok Kuzmolovsky 188663 Russia Details
GSK Investigational Site Pushkin 196603 Russia Details
GSK Investigational Site Saint Petersburg 197022 Russia Details
GSK Investigational Site Saint Petersburg 198255 Russia Details
GSK Investigational Site Yaroslavl 150054 Russia Details
GSK Investigational Site Busan 49241 South Korea Details
GSK Investigational Site Hwasun,Jeollanam-do 58128 South Korea Details
GSK Investigational Site Incheon 21565 South Korea Details
GSK Investigational Site Seongnam-si, Gyeonggi-do 13620 South Korea Details
GSK Investigational Site Seoul 02841 South Korea Details
GSK Investigational Site Seoul 03080 South Korea Details
GSK Investigational Site Seoul 05505 South Korea Details
GSK Investigational Site Seoul 120-752 South Korea Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Barcelona 08908 Spain Details
GSK Investigational Site Madrid 28046 Spain Details
GSK Investigational Site Málaga 29010 Spain Details
GSK Investigational Site Pozuelo de Alarcón/Madrid 28223 Spain Details
GSK Investigational Site Santiago de Compostela 15706 Spain Details
GSK Investigational Site Valencia 46009 Spain Details
GSK Investigational Site Zaragoza 50009 Spain Details
GSK Investigational Site Sankt Gallen 9007 Switzerland Details
GSK Investigational Site Zurich 8091 Switzerland Details
GSK Investigational Site Changhua 50006 Taiwan Details
GSK Investigational Site Kaohsiung City 833 Taiwan Details
GSK Investigational Site Taipei 10002 Taiwan Details
GSK Investigational Site Taipei 112 Taiwan Details
GSK Investigational Site Taipei 11490 Taiwan Details
GSK Investigational Site Taoyuan 333 Taiwan Details
GSK Investigational Site Manchester Lancashire M20 4BX United Kingdom Details
GSK Investigational Site London SW3 6JJ United Kingdom Details
GSK Investigational Site Nottingham NG5 1PB United Kingdom Details
GSK Investigational Site Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field